Who has invested in aXiomatic?

Ares Management are named among the investors backing aXiomatic.

aXiomatic Funding: $61M Raised, Series A (2022)

aXiomatic funding overview

aXiomatic is based in Portsmouth. aXiomatic has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for aXiomatic runs through 2022; nothing later has been disclosed. Investors on record include Ares Management.

aXiomatic at a glance

Total raised: $61M
Latest round: Series A
Latest round date: May 2022
Headquarters: Portsmouth
Notable investors: Ares Management

Frequently asked about aXiomatic funding

How much has aXiomatic raised?: aXiomatic has raised $61M in total disclosed funding across the rounds on record.
Who has invested in aXiomatic?: Ares Management are named among the investors backing aXiomatic.
What was the latest aXiomatic funding round?: The most recent disclosed round is a Series A, announced in May 2022.
Where is aXiomatic based?: aXiomatic is based in Portsmouth.
When did aXiomatic last raise?: The last disclosed aXiomatic round closed in May 2022 at Series A.

Round data for aXiomatic is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Portsmouth and backer lists below.

aXiomatic Funding: $61M Raised, Series A (2022)

aXiomatic funding overview

aXiomatic at a glance

Frequently asked about aXiomatic funding

Companies related to aXiomatic (20)

Browse related funding lists (4)